Bortezomib and extramedullary disease in multiple myeloma: the shine and dark side of the moon. | Leuk Res;31(8): 1153-5, 2007 Aug. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Subject descriptor lookup Advanced Search EVID@Easy

Bortezomib and extramedullary disease in multiple myeloma: the shine and dark side of the moon.

Ali, Ridvan; Ozkalemkas, Fahir; Ozkan, Atilla; Ozkocaman, Vildan; Ozcelik, Tulay; Ozan, Ulku; Kurt, Meral; Tunali, Ahmet.

Leuk Res ; 31(8): 1153-5, 2007 Aug.

Article in En | MEDLINE | ID: mdl-16945413

Subject(s)

Antineoplastic Agents/therapeutic use; Boronic Acids/therapeutic use; Multiple Myeloma/drug therapy; Plasmacytoma/pathology; Pyrazines/therapeutic use; Aged; Bortezomib; Female; Humans; Plasmacytoma/drug therapy; Plasmacytoma/radiotherapy; Treatment Outcome

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Plasmacytoma / Pyrazines / Boronic Acids / Multiple Myeloma / Antineoplastic Agents Limits: Aged / Female / Humans Language: En Journal: Leuk Res Year: 2007 Document type: Article Country of publication: United kingdom

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Plasmacytoma / Pyrazines / Boronic Acids / Multiple Myeloma / Antineoplastic Agents Limits: Aged / Female / Humans Language: En Journal: Leuk Res Year: 2007 Document type: Article Country of publication: United kingdom